Just saw that Oppenheimer upgraded Enhabit (EHAB) back in January - moved from Perform to Outperform. The analyst price target sits around $10.81, which is basically a 0.67% bump from where it was trading at that time. Honestly not a huge move, but the interesting part is what the funds are doing with it.



So there's 328 institutional positions in EHAB, though that actually dropped by 21 holders last quarter. The put/call ratio is sitting at 0.02 which is pretty bullish, but here's where it gets weird - even though Oppenheimer upgraded it, the big money seems mixed. Deerfield Management holds the most at 9.38% but actually reduced their stake. Same story with 8 Knots and UBS, both decreased their positions despite the upgrade.

The company's projecting revenue growth of 17.58% which isn't bad, and non-GAAP EPS around 1.48. But watching the institutional moves, it feels like the smart money isn't as convinced as Oppenheimer seems to be. Could be a contrarian signal worth keeping an eye on.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin